Erythromycin 333 MG Delayed Release Oral Tablet [PCE]

Known as: ERYTHROMYCIN ETHYLSUCCINATE 333 mg ORAL TABLET [PCE], PCE 333 MG Delayed Release Oral Tablet 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
This paper addresses the question of whether collective efficacy affects children’s use of preventive health care. In a low… Expand
  • table 2
  • table 4
  • table 5
  • table 6
  • figure 1
Is this relevant?